|
Friday 1st March 2002 |
Text too small? |
The increased size of the company was evident in the jump in sales for the six-month interim period ending December 2001 from $53.8 million to $121.5 million, with total assets up from $136 million to $277 million and liabilities up from $93 million to $185 million.
After-tax profit was $4.6 million. Directors will consider a dividend at the end of the financial year.
No comments yet
Rua Bioscience Market Update
FSF - Fonterra announces interim leadership changes
April 29th Morning Report
NZK - Blue Endeavour Pilot Farm and Wellboat Update
TRU - FY 31 March 2026 Revenue and Results Guidance Achieved
FBU - Fletcher Building sale of Fletcher Reinforcing and Wire
April 28th Morning Report
RYM - Ryman Healthcare appoints new independent director
ikeGPS 4Q FY26 and Full Year FY26 Performance Update
HGH - Heartland trading update